Insulin requirements in patients with diabetes and declining kidney function: Differences between insulin analogues and human insulin?

Therapeutic Advances in Endocrinology and Metabolism

Volumn 4, Issue 4, 2013, Pages 113-121

  Kulozik, Felix ^a   Hasslacher, Christoph ^b  

^a Diabetesinstitut Heidelberg ^*  (Germany)

^b Diabetesinstitut Heidelberg   (Germany)

Author keywords

diabetic nephropathy; human insulin; insulin analogues; insulin aspart; insulin detemir; insulin glargin; insulin lispro; insulin requirement; renal insufficiency

Indexed keywords

HUMAN INSULIN; HUMINSULIN BASAL; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN; NEUTRAL INSULIN; RECOMBINANT HUMAN INSULIN; SHORT ACTING INSULIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL CLASSIFICATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL PARAMETERS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84883303101     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018813501188     Document Type: Article

References (18)

1. Alvestrand A. Mujagic M. Wajngot A. Efendic S. (1989) Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance. Clin Nephrol 31: 175–183.
2. Biesenbach G. Raml A. Schmekal B. Eichbauer-Sturm G. (2003) Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. Diabet Med J Br Diabet Assoc 20: 642–645.
3. Bolli G. Hahn A. Schmidt R. Eisenblaetter T. Dahmen R. Heise T. et al. (2012) Plasma exposure to insulin glargine and its metabolites M 1 and M 2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes. Diabetes Care 35: 2626–2630.
4. Charlesworth J. Kriketos A. Jones J. Erlich J. Campbell L. Peake P. (2005) Insulin resistance and postprandial triglyceride levels in primary renal disease. Metabolism 54: 821–828.
5. Duckworth W. Bennett R. Hamel F. (1998) Insulin degradation: progress and potential. Endocr Rev 19: 608–624.
6. Eidemak I. Feldt-Rasmussen B. Kanstrup I. Nielsen S. Schmitz O. Strandgaard S. (1995). Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 38: 565–572.
7. Ferrannini E. Wahren J. Faber O. Felig P. Binder C. DeFronzo R. (1983). Splanchnic and renal metabolism of insulin in human subjects: a dose–response study. Am J Physiol 244: E517–E527.
8. Gaede P. Vedel P. Larsen N. Jensen G. Parving H. Pedersen O. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383–393.
9. Hasslacher C. Vogt C. Raupp D. Dreyhaupt J. (2007). [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin]. Dtsch Med Wochenschr 1946 132: 2500–2504.
10. Holmes G. Galitz L. Hu P. Lyness W. (2005). Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment. Br J Clin Pharmacol 60: 469–476.
11. Iglesias P. Díez J. (2008) Insulin therapy in renal disease. Diabetes Obes Metab 10: 811–823.
12. Lindholm A. Jacobsen L. (2001) Clinical pharmacokinetics and pharmacodynamics of insulin aspart. Clin Pharmacokinet 40: 641–659.
13. Nielsen S. (1992) Time course and kinetics of proximal tubular processing of insulin. Am J Physiol 262: F813–F822.
14. Rabkin R. Ryan M. Duckworth W. (1984). The renal metabolism of insulin. Diabetologia 27: 351–357.
15. Rave K. Heise T. Pfützner A. Heinemann L. Sawicki P. (2001) Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients. Diabetes Care 24: 886–890.
16. Svensson M. Yu Z. Eriksson J. (2002). A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephropathy. Eur J Clin Invest 32: 100–109.
17. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986.
18. Zoungas S. Patel A. Chalmers J. de Galan B. Li Q. Billot L. et al. (2010) Severe hypoglycemia and risks of vascular events and death. N Engl J Med 363: 1410–1418.